{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:10:46Z","timestamp":1790824246900,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"7","funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AI099850"],"award-info":[{"award-number":["R21 AI099850"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,13]]},"DOI":"10.1093\/infdis\/jix689","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T07:07:17Z","timestamp":1514531237000},"page":"1110-1117","source":"Crossref","is-referenced-by-count":54,"title":["The Existing Drug Vorinostat as a New Lead Against Cryptosporidiosis by Targeting the Parasite Histone Deacetylases"],"prefix":"10.1093","volume":"217","author":[{"given":"Fengguang","family":"Guo","sequence":"first","affiliation":[{"name":"Key Laboratory for Zoonoses Research, Ministry of Education, Institute of Zoonosis, Jilin University, Changchun, China"},{"name":"Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haili","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina N","family":"McNair","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan R","family":"Mead","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University, Atlanta, Georgia"},{"name":"Atlanta Veterans Affairs Medical Center, Decatur, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"key":"key\n\t\t\t\t20180626074827_CIT0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000060370","article-title":"The biology of Cryptosporidium","volume":"6","author":"Tzipori","year":"2000","journal-title":"Contrib Microbiol"},{"key":"key\n\t\t\t\t20180626074827_CIT0002","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMra013170","article-title":"Cryptosporidiosis","volume":"346","author":"Chen","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180626074827_CIT0003","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1086\/368194","article-title":"Cryptosporidium species: new insights and old challenges","volume":"36","author":"Leav","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180626074827_CIT0004","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1001\/jama.2016.7833","article-title":"Persistent diarrhea: a clinical review","volume":"315","author":"DuPont","year":"2016","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180626074827_CIT0005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cmi.2016.04.021","article-title":"Human cryptosporidiosis in Europe","volume":"22","author":"Cacci\u00f2","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180626074827_CIT0006","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MOG.0000000000000135","article-title":"The intestinal protozoa: emerging impact on global health and development","volume":"31","author":"Turkeltaub","year":"2015","journal-title":"Curr Opin Gastroenterol"},{"key":"key\n\t\t\t\t20180626074827_CIT0007","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(14)70772-8","article-title":"A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for Cryptosporidium","volume":"15","author":"Checkley","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180626074827_CIT0008","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/QAD.0b013e3283437e88","article-title":"Cryptosporidiosis in patients with HIV\/AIDS","volume":"25","author":"O\u2019connor","year":"2011","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180626074827_CIT0009","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180626074827_CIT0010","doi-asserted-by":"crossref","first-page":"e0004729","DOI":"10.1371\/journal.pntd.0004729","article-title":"The burden of Cryptosporidium diarrheal disease among children < 24 months of age in moderate\/high mortality regions of sub-Saharan Africa and South Asia, utilizing data from the Global Enteric Multicenter Study (GEMS)","volume":"10","author":"Sow","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180626074827_CIT0011","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(16)31529-X","article-title":"Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180626074827_CIT0012","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2174\/1389450116666150806124110","article-title":"New antimicrobial approaches: reuse of old drugs","volume":"17","author":"Savoia","year":"2016","journal-title":"Curr Drug Targets"},{"key":"key\n\t\t\t\t20180626074827_CIT0013","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0022-3859.81870","article-title":"Drug repositioning: re-investigating existing drugs for new therapeutic indications","volume":"57","author":"Padhy","year":"2011","journal-title":"J Postgrad Med"},{"key":"key\n\t\t\t\t20180626074827_CIT0014","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t20180626074827_CIT0015","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1128\/AAC.02460-12","article-title":"Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth","volume":"57","author":"Bessoff","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626074827_CIT0016","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3389\/fmicb.2015.00991","article-title":"Quantitative RT-PCR assay for high-throughput screening (HTS) of drugs against the growth of Cryptosporidium parvum in vitro","volume":"6","author":"Zhang","year":"2015","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20180626074827_CIT0017","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijpara.2008.11.012","article-title":"An apicomplexan ankyrin-repeat histone deacetylase with relatives in photosynthetic eukaryotes","volume":"39","author":"Rider","year":"2009","journal-title":"Int J Parasitol"},{"key":"key\n\t\t\t\t20180626074827_CIT0018","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/jit645","article-title":"Amelioration of Cryptosporidium parvum infection in vitro and in vivo by targeting parasite fatty acyl-coenzyme A synthetases","volume":"209","author":"Guo","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626074827_CIT0019","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1645\/0022-3395(2002)088[1014:STCPII]2.0.CO;2","article-title":"Susceptibility to Cryptosporidium parvum infections in cytokine- and chemokine-receptor knockout mice","volume":"88","author":"Campbell","year":"2002","journal-title":"J Parasitol"},{"key":"key\n\t\t\t\t20180626074827_CIT0020","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2307\/3283822","article-title":"A new method for evaluating experimental cryptosporidial parasite loads using immunofluorescent flow cytometry","volume":"81","author":"Arrowood","year":"1995","journal-title":"J Parasitol"},{"key":"key\n\t\t\t\t20180626074827_CIT0021","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t20180626074827_CIT0022","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nm.2758","article-title":"A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target","volume":"18","author":"Debnath","year":"2012","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180626074827_CIT0023","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4161\/gmic.22596","article-title":"Reprofiled drug targets ancient protozoans: drug discovery for parasitic diarrheal diseases","volume":"4","author":"Debnath","year":"2013","journal-title":"Gut Microbes"},{"key":"key\n\t\t\t\t20180626074827_CIT0024","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2307\/3284020","article-title":"Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum","volume":"81","author":"Healey","year":"1995","journal-title":"J Parasitol"},{"key":"key\n\t\t\t\t20180626074827_CIT0025","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1086\/428839","article-title":"Nitazoxanide: a new thiazolide antiparasitic agent","volume":"40","author":"Fox","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180626074827_CIT0026","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4269\/ajtmh.2003.68.382","article-title":"Nitazoxanide: an important advance in anti-parasitic therapy","volume":"68","author":"White","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180626074827_CIT0027","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.exppara.2008.12.014","article-title":"Cryptosporidium: genomic and biochemical features","volume":"124","author":"Rider","year":"2010","journal-title":"Exp Parasitol"},{"key":"key\n\t\t\t\t20180626074827_CIT0028","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/infdis\/jit327","article-title":"A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis","volume":"208","author":"Castellanos-Gonzalez","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626074827_CIT0029","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1128\/AAC.02075-13","article-title":"Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis","volume":"58","author":"Gorla","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626074827_CIT0030","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature22337","article-title":"A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis","volume":"546","author":"Manjunatha","year":"2017","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180626074827_CIT0031","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt1272","article-title":"Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug","volume":"25","author":"Marks","year":"2007","journal-title":"Nat Biotechnol"},{"key":"key\n\t\t\t\t20180626074827_CIT0032","doi-asserted-by":"crossref","first-page":"e1005237","DOI":"10.1371\/journal.ppat.1005237","article-title":"Modeling the effects of vorinostat in vivo reveals both transient and delayed HIV transcriptional activation and minimal killing of latently infected cells","volume":"11","author":"Ke","year":"2015","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20180626074827_CIT0033","doi-asserted-by":"crossref","first-page":"e1004473","DOI":"10.1371\/journal.ppat.1004473","article-title":"Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy","volume":"10","author":"Elliott","year":"2014","journal-title":"PLoS Pathog"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/217\/7\/1110\/25090668\/jix689.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T17:03:29Z","timestamp":1570554209000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/217\/7\/1110\/4782507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,2]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,1,2]]},"published-print":{"date-parts":[[2018,3,13]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix689","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4,1]]},"published":{"date-parts":[[2018,1,2]]}}}